USD
$0.00
(0.00%
)At Close (As of Nov 26, 2025)
$1.16B
Market Cap
121.32
P/E Ratio
0.19
EPS
$45.16
52 Week High
$20.12
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $271M |
| Total Revenue | $2B |
| Cost Of Revenue | $1.8B |
| Costof Goods And Services Sold | $1.8B |
| Operating Income | $89M |
| Selling General And Administrative | $154M |
| Research And Development | - |
| Operating Expenses | $182M |
| Investment Income Net | - |
| Net Interest Income | -$19M |
| Interest Income | $15M |
| Interest Expense | $33M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $28M |
| Income Before Tax | $81M |
| Income Tax Expense | $31M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $50M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $114M |
| Ebitda | $142M |
| Net Income | $43M |
| Field | Value (USD) |
|---|---|
| Total Assets | $1.4B |
| Total Current Assets | $638M |
| Cash And Cash Equivalents At Carrying Value | $288M |
| Cash And Short Term Investments | $288M |
| Inventory | - |
| Current Net Receivables | $325M |
| Total Non Current Assets | $716M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $118M |
| Intangible Assets Excluding Goodwill | $118M |
| Goodwill | $419M |
| Investments | - |
| Long Term Investments | $48M |
| Short Term Investments | $2.4M |
| Other Current Assets | $23M |
| Other Non Current Assets | - |
| Total Liabilities | $841M |
| Total Current Liabilities | $366M |
| Current Accounts Payable | $15M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $15M |
| Total Non Current Liabilities | $475M |
| Capital Lease Obligations | $37M |
| Long Term Debt | $425M |
| Current Long Term Debt | $9.4M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $472M |
| Other Current Liabilities | $323M |
| Other Non Current Liabilities | $14M |
| Total Shareholder Equity | $713M |
| Treasury Stock | - |
| Retained Earnings | $286M |
| Common Stock | $48K |
| Common Stock Shares Outstanding | $48M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $52M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $28M |
| Capital Expenditures | $8M |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$192M |
| Cashflow From Financing | $135M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $4M |
| Dividend Payout Common Stock | $4M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$937K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $50M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $271M |
| Total Revenue | $2B |
| Cost Of Revenue | $1.8B |
| Costof Goods And Services Sold | $1.8B |
| Operating Income | $89M |
| Selling General And Administrative | $154M |
| Research And Development | - |
| Operating Expenses | $182M |
| Investment Income Net | - |
| Net Interest Income | -$19M |
| Interest Income | $15M |
| Interest Expense | $33M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $28M |
| Income Before Tax | $81M |
| Income Tax Expense | $31M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $50M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $114M |
| Ebitda | $142M |
| Net Income | $43M |
Sector: HEALTHCARE
Industry: MEDICAL CARE FACILITIES
Astrana Health, Inc. is an innovative healthcare management enterprise based in Alhambra, California, focused on revolutionizing medical care through technology-driven solutions. Committed to a physician-centric and patient-centered approach, the company aims to improve health outcomes and operational efficiencies for healthcare providers nationwide. With a strategic emphasis on cutting-edge integration and personalized services, Astrana Health is well-positioned to meet the evolving demands of the healthcare landscape, driving scalable improvements in care delivery and patient engagement.